Christian Schmidt, gempex
According to Annex 1, letters c and d, of the Medicinal Products Licensing Ordinance (MPLO), most parts of EU-GMP is valid in Switzerland. What might sound easy is not always the case. Not all of the current EU-GMP guidance is listed and sometimes it is not possible to implement updates in a timely manner.
In individual cases, there are also divergent requirements or different interpretations by the authorities.
This Webinar has been designed for QA/GMP personnel and management functions who would like to get a comprehensive overview on the differences between Suisse and EU GMP/GDP.
For our webinars, we use Cisco WebEx, one of the leading suppliers of online meetings. At http://www.webex.com/test-meeting.html you can check if your system meets the necessary requirements for the participation at a WebEx meeting and at the same time install the necessary plug-in. Please just enter your name and email address for the test. If the installation is not possible because of your rights for the computer system, please contact your IT department. WebEx is a standard nowadays and the necessary installation is fast and easy.
Learn and discuss the following topics:
- The Role of SwissMedic and the local inspectorates
- Specific differences and how to deal with them
- RP and QP
- Implementation of new EU Guidance documents in Switzerland
- The Mutual Recognition Agreement (MRA) : facilitation and constraints